4-(Benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione

Catalog No. :
ACPADO057
CAS No. :
2642218-43-5
Molecular Formula :
C23H21NO3
Molecular Weight :
359.42

IUPAC Name:4-(benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione

4-(Benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$86.00Login to see priceIn stockInquiry
5mg98%$133.00Login to see priceIn stockInquiry
10mg98%$198.00Login to see priceIn stockInquiry
25mg98%$338.00Login to see priceIn stockInquiry
50mg98%$474.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione
IUPAC Name4-(benzyloxy)-3,3-diethyl-2H-benzo[g]indole-2,5(3H)-dione
Molecular FormulaC23H21NO3
Molecular Weight359.42
SMILESO=C(C(CC)(CC)C1=C2OCC3=CC=CC=C3)N=C1C4=CC=CC=C4C2=O
InChI KeyOEWZCENSPLZNPQ-UHFFFAOYSA-N
Synonym2H-Benz[g]indole-2,5(3H)-dione, 3,3-diethyl-4-(phenylmethoxy)-;RIG012, 10 mM in DMSO
CAS No.2642218-43-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPADO057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPADO057 route product structure diagram
    ACPADO0572642218-43-5 In Stock
Inquiry

2. ACPADO057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPADO057 route product structure diagram
    ACPADO0572642218-43-5 In Stock
Inquiry

Comments (0)